CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 68 filers reported holding CHEMOCENTRYX INC in Q3 2013. The put-call ratio across all filers is 3.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,387,000 | +1524.1% | 588,213 | +679.1% | 0.02% | +1400.0% |
| Q2 2022 | $1,871,000 | +19.6% | 75,500 | +21.0% | 0.00% | 0.0% |
| Q1 2022 | $1,564,000 | -31.0% | 62,400 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $2,268,000 | +109.6% | 62,300 | -1.6% | 0.00% | – |
| Q3 2021 | $1,082,000 | +14.1% | 63,300 | -10.6% | 0.00% | – |
| Q2 2021 | $948,000 | -81.0% | 70,800 | -27.3% | 0.00% | -100.0% |
| Q1 2021 | $4,988,000 | -16.7% | 97,341 | +0.6% | 0.00% | -33.3% |
| Q4 2020 | $5,990,000 | +6.1% | 96,741 | -6.1% | 0.00% | 0.0% |
| Q3 2020 | $5,647,000 | -13.6% | 103,041 | -9.3% | 0.00% | -25.0% |
| Q2 2020 | $6,535,000 | +58.4% | 113,580 | +10.6% | 0.00% | +33.3% |
| Q1 2020 | $4,126,000 | +18.4% | 102,680 | +16.5% | 0.00% | +50.0% |
| Q4 2019 | $3,486,000 | +767.2% | 88,150 | +48.7% | 0.00% | – |
| Q3 2019 | $402,000 | -27.0% | 59,300 | 0.0% | 0.00% | – |
| Q2 2019 | $551,000 | -14.7% | 59,300 | +27.5% | 0.00% | – |
| Q1 2019 | $646,000 | +26.9% | 46,500 | -0.4% | 0.00% | – |
| Q4 2018 | $509,000 | -13.7% | 46,700 | 0.0% | 0.00% | – |
| Q3 2018 | $590,000 | -4.1% | 46,700 | 0.0% | 0.00% | – |
| Q2 2018 | $615,000 | +12.8% | 46,700 | +16.5% | 0.00% | – |
| Q1 2018 | $545,000 | +144.4% | 40,100 | +6.9% | 0.00% | – |
| Q4 2017 | $223,000 | -19.8% | 37,500 | 0.0% | 0.00% | – |
| Q3 2017 | $278,000 | -81.4% | 37,500 | -76.5% | 0.00% | -100.0% |
| Q2 2017 | $1,495,000 | +14.0% | 159,687 | -11.3% | 0.00% | 0.0% |
| Q1 2017 | $1,311,000 | -56.7% | 180,087 | -56.0% | 0.00% | -66.7% |
| Q4 2016 | $3,031,000 | +1486.9% | 409,640 | +1192.2% | 0.00% | – |
| Q3 2016 | $191,000 | +34.5% | 31,700 | 0.0% | 0.00% | – |
| Q2 2016 | $142,000 | +343.8% | 31,700 | +637.2% | 0.00% | – |
| Q1 2015 | $32,000 | +18.5% | 4,300 | +10.3% | 0.00% | – |
| Q4 2014 | $27,000 | +28.6% | 3,900 | -17.0% | 0.00% | – |
| Q3 2014 | $21,000 | -22.2% | 4,700 | 0.0% | 0.00% | – |
| Q2 2014 | $27,000 | -44.9% | 4,700 | -36.5% | 0.00% | – |
| Q1 2014 | $49,000 | -46.2% | 7,400 | -53.1% | 0.00% | – |
| Q4 2013 | $91,000 | -35.0% | 15,782 | -37.4% | 0.00% | – |
| Q3 2013 | $140,000 | -71.9% | 25,217 | -28.5% | 0.00% | -100.0% |
| Q2 2013 | $499,000 | – | 35,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |